Long-term outcome and safety of prolonged bedaquiline treatment for multidrug-resistant tuberculosis

Lorenzo Guglielmetti, Marie Jaspard, Damien Le Dû, Marie Lachâtre, Dhiba Marigot-Outtandy, Christine Bernard, Nicolas Veziris, Jérôme Robert, Yazdan Yazdanpanah, Eric Caumes, Mathilde Fréchet-Jachym for the French MDR-TB Management Group

Source: Eur Respir J , 49 (3) 1601799; DOI: 10.1183/13993003.01799-2016
Journal Issue: March
Disease area: Respiratory infections

Congress or journal article abstractFull text journal articlePDF journal article, handout or slidesCME test or case report

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Lorenzo Guglielmetti, Marie Jaspard, Damien Le Dû, Marie Lachâtre, Dhiba Marigot-Outtandy, Christine Bernard, Nicolas Veziris, Jérôme Robert, Yazdan Yazdanpanah, Eric Caumes, Mathilde Fréchet-Jachym for the French MDR-TB Management Group. Long-term outcome and safety of prolonged bedaquiline treatment for multidrug-resistant tuberculosis. Eur Respir J , 49 (3) 1601799; DOI: 10.1183/13993003.01799-2016

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: